ACR Urges the FTC to Examine the Impact of Pharmacy Benefit Managers on Prescription Drug Costs

In comments submitted to the Federal Trade Commission (FTC), the American College of Rheumatology (ACR) urged the agency to address Pharmacy Benefit Manager (PBM) business practices that drive up costs and reduce access for the 54 million Americans living with rheumatic disease.